This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Role of Greyscale and Power Doppler Sonography in Therapy Monitoring in Early Rheumatoid Arthritis (RA)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2009 by Cairo University.
Recruitment status was:  Not yet recruiting
Information provided by:
Cairo University Identifier:
First received: March 2, 2009
Last updated: NA
Last verified: March 2009
History: No changes posted
The purpose of this study is to evaluate the role of musculoskeletal ultrasound and power Doppler in early therapy monitoring of rheumatoid arthritis patients.

Rheumatoid Arthritis

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Therapy Monitoring in Early Rheumatoid Arthritis: The Role of Greyscale and Power Doppler Sonography A Prospective Study Of 20 Egyptian Rheumatoid Arthritis Patients

Resource links provided by NLM:

Further study details as provided by Cairo University:

Estimated Enrollment: 20
Study Start Date: April 2009
Estimated Study Completion Date: April 2010
Estimated Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Adult onset Rheumatoia Arthritis patients with a disease duration of less than 3 months

Inclusion Criteria:

  • Adults: age at disease onset >18 years and < 50 years
  • Disease duration < 3 month
  • Fulfilling ARA criteria for classification of RA
  • DMARD naive

Exclusion Criteria:

  • Age at diagnosis < 18 years
  • Disease duration > 3 month
  • Previous use of DMARDS
  • Previous use of biologics
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

Responsible Party: Ghada El-Mardenly, Cairo University Identifier: NCT00854243     History of Changes
Other Study ID Numbers: RA1
Study First Received: March 2, 2009
Last Updated: March 2, 2009

Additional relevant MeSH terms:
Arthritis, Rheumatoid
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Connective Tissue Diseases
Autoimmune Diseases
Immune System Diseases processed this record on August 16, 2017